Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients.

Takao Katoh Kousaku KawashimaNobuhiko FukubaShigeto MasudaHiroko KobatakeKousaku MasakiYasuhiro ArakiKoichiro KawanoKatsuhisa NishiMamoru TakenakaShunji IshiharaYoshikazu Kinoshita

Published in: Journal of gastroenterology and hepatology (2019)

Prophylactic low-dose rectal diclofenac did not reduce the incidence of PEP following ERCP in patients classified as low or high risk.

Keyphrases

low dose
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
high dose
risk factors
rectal cancer
patient reported outcomes